Trans-ccc_R08
Trans-ccc_R08 (compound 1-B) is a potent cccDNA (covalently closed circular DMA) inhibitor. trans-ccc_R08 inhibits HBeAg level with an IC50 value of 0.08 µM. trans-ccc_R08 has the potential for the research of Hepatitis B Virus infection (HBV) [1].
Product Specifications
CAS Number
[2413192-49-9]
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/trans-ccc-r08.html
Purity
99.71
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C=C(C2=CC=C(C=C2)OCCO[C@@H]3C[C@H](C3)C(O)=O)OC4=C(Cl)C=CC=C41
Molecular Formula
C22H19ClO6
Molecular Weight
414.84
References & Citations
[1]Song Feng, et al. Flavone compounds for the treatment and prophylaxis of hepatitis b virus disease. WO2020053249A1.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human CLDN6 sgRNA gene knockout kit - Lentiviral human CLDN6 sgRNA gene knockout kit (plasmid)
